chr3-32391971-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138410.4(CMTM7):c.65C>T(p.Ala22Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000926 in 1,079,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_138410.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMTM7 | NM_138410.4 | c.65C>T | p.Ala22Val | missense_variant | 1/5 | ENST00000334983.10 | NP_612419.1 | |
CMTM7 | NM_181472.3 | c.65C>T | p.Ala22Val | missense_variant | 1/4 | NP_852137.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CMTM7 | ENST00000334983.10 | c.65C>T | p.Ala22Val | missense_variant | 1/5 | 1 | NM_138410.4 | ENSP00000335605 | P1 | |
CMTM7 | ENST00000349718.8 | c.65C>T | p.Ala22Val | missense_variant | 1/4 | 1 | ENSP00000283621 | |||
CMTM7 | ENST00000454304.6 | c.65C>T | p.Ala22Val | missense_variant, NMD_transcript_variant | 1/5 | 5 | ENSP00000414480 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 9.26e-7 AC: 1AN: 1079898Hom.: 0 Cov.: 32 AF XY: 0.00000196 AC XY: 1AN XY: 510244
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 03, 2024 | The c.65C>T (p.A22V) alteration is located in exon 1 (coding exon 1) of the CMTM7 gene. This alteration results from a C to T substitution at nucleotide position 65, causing the alanine (A) at amino acid position 22 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at